Group One Trading’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.8K Sell
600
-1,500
-71% -$36.7K ﹤0.01% 6287
2025
Q4
$56.2K Buy
2,100
+400
+24% +$10.3K ﹤0.01% 5502
2025
Q3
$45.3K Buy
1,700
+700
+70% +$18.1K ﹤0.01% 6043
2025
Q2
$23K Buy
+1,000
New +$24.8K ﹤0.01% 6172
2025
Q1
Sell
-100
Closed -$3.71K 7527
2024
Q4
$3.71K Sell
100
-4,300
-98% -$197K ﹤0.01% 6539
2024
Q3
$214K Buy
4,400
+3,700
+529% +$162K ﹤0.01% 3559
2024
Q2
$28K Sell
700
-2,300
-77% -$95.3K ﹤0.01% 4974
2024
Q1
$132K Buy
+3,000
New +$155K ﹤0.01% 3896
2023
Q4
Sell
-1,800
Closed -$82.8K 7323
2023
Q3
$82.8K Buy
1,800
+1,300
+260% +$70.9K ﹤0.01% 4626
2023
Q2
$28.7K Buy
+500
New +$22.2K ﹤0.01% 5711
2023
Q1
Sell
-300
Closed -$8.41K 7143
2022
Q4
$8.41K Sell
300
-200
-40% -$5.81K ﹤0.01% 6094
2022
Q3
$14K Sell
500
-2,100
-81% -$68.6K ﹤0.01% 6278
2022
Q2
$90K Buy
2,600
+1,900
+271% +$67.8K ﹤0.01% 5075
2022
Q1
$25K Buy
+700
New +$19.9K ﹤0.01% 6599
2016
Q4
Sell
-5,300
Closed -$101K 4394
2016
Q3
$101K Buy
5,300
+2,800
+112% +$50.8K ﹤0.01% 2916
2016
Q2
$40K Buy
+2,500
New +$35.3K ﹤0.01% 3434

Other funds holding AMPH

Group One Trading's AMPH Position: Q1 2026 in Review

Group One Trading reduced its Amphastar Pharmaceuticals (AMPH) stake by 88% in Q1 2026, selling an estimated $37.4K and leaving 214 shares worth $4.19K. The position accounts for ﹤0.01% of the portfolio, ranked #6782.

Group One Trading first reported a position in AMPH in Q4 2016 and has held it in 12 quarters since. The position peaked at $133K in Q2 2022. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • Group One Trading held 214 shares of Amphastar Pharmaceuticals worth $4.19K as of Q1 2026.
  • Group One Trading sold 1,527 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $37.4K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #6782 holding.
  • Group One Trading first reported a position in Amphastar Pharmaceuticals in Q4 2016 and has held it in 12 quarters since.
  • Group One Trading's Amphastar Pharmaceuticals position peaked at $133K in Q2 2022.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.